Advisory Board

Peter Mørch Eriksen currently serves as the CEO of the lifescience company BioPorto Lid. With over 25 years of experience in the MedTech and life science industries, including roles as CEO of Sense A/S and VP of Medtronic, He has a proven track record in the medical device industry, possessing broad experience in the development and commercialization of medical devices for both small and large MedTech companies. Peter’s background in accounting, complemented by his management experience, further enhances his leadership capabilities.

Other directorships: FluoGuide A/S (Chair), Monsenso A/S (Chair), AptaShape ApS (Board Member), PME Holding ApS.

Max Graziosi is an Italian executive with a multifaceted career spanning finance, technology, and healthcare.

Following a 25-year tenure in London, where he held senior roles at some of the world’s leading financial institutions, Max transitioned into the healthcare sector. He now serves as a board member and director of Orthonika Limited, a London-based MedTech company focused on pioneering total meniscus replacement solutions.

In addition, he is a Financial Consultant and active member of the Quadrans Foundation, a Swiss nonprofit committed to advancing blockchain infrastructure and fostering decentralized innovation.

Max holds a bachelor’s degree in economics from Northwestern University in the United States.